Advanced search
Publication Cover
Renal Failure Volume 34, 2012 - Issue 2
Submit an article Journal homepage
995
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Ranolazine, Tacrolimus, and Diltiazem Might be a Hazardous Combination in a Transplant Patient

Hitesh PatniDivision of Kidney Diseases and Hypertension, Department of Internal Medicine, Hofstra-North Shore-LIJ School of Medicine, Hofstra University, Great Neck, NY, USACorrespondence[email protected]
,
Michael GitmanDivision of Kidney Diseases and Hypertension, Department of Internal Medicine, Hofstra-North Shore-LIJ School of Medicine, Hofstra University, Great Neck, NY, USA
,
Azzour HazzanDivision of Kidney Diseases and Hypertension, Department of Internal Medicine, Hofstra-North Shore-LIJ School of Medicine, Hofstra University, Great Neck, NY, USA
&
Kenar D. JhaveriDivision of Kidney Diseases and Hypertension, Department of Internal Medicine, Hofstra-North Shore-LIJ School of Medicine, Hofstra University, Great Neck, NY, USA
Pages 251-253 | Received 28 Jul 2011, Accepted 12 Oct 2011, Published online: 23 Jan 2012

REFERENCES

  • Chaitman B. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular condition. Circulation. 2006;113:2462–2472.
  • Stone PH, Gratsiansky NA, Blokhin A, . Antianginal efficacy of ranolazine when added to treatment with amlodipine: The ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol. 2006;48:566–575.
  • Chaitman BR, Pepine CJ, Parker JO, . Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial. J Am Med Assoc. 2004;291:309–316.
  • Jerling M. Clinical pharmacokinetics of ranolazine. Clin Pharmacokinet. 2006;45:469–491.
  • Jerling M, Abdallah H. Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine. Clin Pharmacol Ther. 2005;78:288–297.
  • Jones T, Morris R. Pharmacokinetic interaction between tacrolimus and diltiazem: Dose-response relationship in kidney and liver transplant recipients. Clin Pharmacokinet. 2002;41:381–388.
  • Ranolazine [package insert]. Foster City, CA: Gilead Palo Alto; 2006.
  • Lodge JP, Lam FT, Perry SL, . Ranolazine—A new drug with beneficial effects on renal preservation. Transplantation. 1990;50:755–759.
  • Seck S, Bellantoni M, Zoccali C, Enia G. Ranolazine can markedly increase tacrolimus blood levels. Nephron Dial Transplant Plus. 2010, doi:10.1093/ndtplus/sfq180.
  • Pierce D, Reeves-Daniel A. Ranolazine-tacrolimus interaction. Ann Pharmacother. 2010;44(11):1844–1849.
  • Horn J, Hansten P, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;47:674–680.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.